Ionis Pharmaceuticals
Price & Volume
Stats
See more52W Range | $27.57-$86.74 |
Market Cap | $12.4B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $943.7M |
Revenue Growth (YoY) | -10.3% |
Gross Profit (12 Mos) | $12.1M |
Diluted EPS | -$2.38 |
News
See moreYahoo Finance • 10 hours ago
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
Yahoo Finance • 3 days ago
Nike downgraded, IBM initiated: Wall Street's top analyst calls
Yahoo Finance • 14 days ago
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
Yahoo Finance • 17 days ago
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares
About
CEO | Dr. Brett P. Monia Ph.D. |
CFO | Ms. Elizabeth L. Hougen M.A., M.B.A., M.S. |
Address | 2855 Gazelle Court, Carlsbad, CA, United States, 92010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,402 |
